ReviewEmerging infectious diseases2023
Bacterial Agents Detected in 418 Ticks Removed from Humans during 2014-2021, France.
Review in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- Pediatric Rickettsia massiliae Infection, Spain, 2023.Emerging infectious diseases · 2026Article
- Tick-Borne Infections: Results from a Prospective Observational Study from a Single Centre in Northern Italy.Pathogens (Basel, Switzerland) · 2026Observational
- Consultations in general practice related to a tick bite episode in mainland France in 2023-2024.BMC public health · 2026Article
- "Giant tick" attacks: dynamics of Hyalomma lusitanicum and detection of Rickettsia sibirica mongolitimonae in southern France.Parasite (Paris, France) · 2026Article
- Variety of Bacterial Pathogens in Ticks Removed from Humans, Northeastern China.Microorganisms · 2025Article
- Prevalence ofPathogens (Basel, Switzerland) · 2025Article
- Occurrence of Ticks and Tick-Borne Pathogens During Warm Winter-A Snapshot from Central Europe.Pathogens (Basel, Switzerland) · 2025Article
- The prevalence of pathogens in ticks collected from humans in Belgium, 2021, versus 2017.Parasites & vectors · 2024Article
- Applying MALDI-TOF MS to resolve morphologic and genetic similarities between two Dermacentor tick species of public health importance.Scientific reports · 2024Article
- Prevalence of Lyme Disease and Relapsing FeverPathogens (Basel, Switzerland) · 2024Review
- Non-vaccinal prophylaxis of tularemia.Frontiers in microbiology · 2024Review
- Diversity of species and geographic distribution of tick-borne viruses in China.Frontiers in microbiology · 2024Article
- Molecular Survey ofVeterinary sciences · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monitoring of tickborne diseases is critical for prevention and management. We analyzed 418 ticks removed from 359 patients during 2014-2021 in Marseille, France, for identification and bacteria detection. Using morphology, molecular methods, or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, we identified 197 (47%) Ixodes, 136 (33%) Dermacentor, 67 (16%) Rhipicephalus, 8 (2%) Hyalomma, 6 (1%) Amblyomma, 2 (0.5%) Argas, and 2 (0.5%) Haemaphysalis tick species. We also detected bacterial DNA in 241 (58%) ticks. The most frequent bacterial pathogens were Rickettsia raoultii (17%) and R. slovaca (13%) in Dermacentor ticks, Borrelia spp. (9%) in Ixodes ticks, and R. massiliae (16%) in Rhipicephalus ticks. Among patients who were bitten, 107 had symptoms, and tickborne diseases were diagnosed in 26, including scalp eschar and neck lymphadenopathy after tick bite and Lyme borrelioses. Rapid tick and bacteria identification using a combination of methods can substantially contribute to clinical diagnosis, treatment, and surveillance of tickborne diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.